Catheter Ablation Using a Novel Navigation and Imaging System
ConditionParoxysmal Atrial Fibrillation
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLUMA Vision Ltd.
About this trial
The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paroxysmal Atrial Fibrillation (PAF).
Eligibility criteria
Qualifiers
Subject is 18 years of age at the time of consent, or of legal age to give informed consent specific to state and national law
Subjects is eligible for a catheter ablation procedure with the VERAFEYE System as navigation and imaging system in the treatment of PAF (according to VERAFEYE System IFUs, current international and local guidelines and per physician discretion)
Subject is able to understand and willing to provide written informed consent
Subject is able to and willing to complete all study assessments associated with this clinical study at an approved clinical investigational center
Disqualifiers
None
Trial design
Treatments tested in this trial
- VERAFEYE System
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov